Glycopeptides and nephrotoxicity.
Intensive Care Med
; 20 Suppl 4: S23-9, 1994 Nov.
Article
en En
| MEDLINE
| ID: mdl-7699153
ABSTRACT
Infections due to Gram-positive bacteria have become an increasing problem in the ICU. Furthermore, multidrug resistance among Gram-positive pathogens is increasingly recognized. Empirical therapy with antibiotic regimens that are effective against Gram-positive pathogens is often required in the ICU. Many critically ill patients in the ICU have multiorgan system failure, including acute renal failure, which further impedes optimal antimicrobial therapy. In this communication, the use of glycopeptides in the ICU is briefly reviewed, and the occurrence of associated nephrotoxicity during therapy with vancomycin or teicoplanin, alone or in combination with an aminoglycoside, is examined. Finally, existing recommendations regarding the dose regimens of these agents in patients with renal impairment are evaluated, and guide-lines for optimizing glycopeptide therapy through improved pharmacokinetic monitoring are presented.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Insuficiencia Renal
/
Antibacterianos
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Intensive Care Med
Año:
1994
Tipo del documento:
Article
País de afiliación:
Canadá